Company Name or Ticker Symbol
Search for other Categories
Axim Biotechnologies, Inc.  (AXIM)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs


Redemption of Losses, Sharp Topline Growth

decrease font size NEWS BETA Increase font size

Axim Biotechnologies, Inc announced first quarter 2017 operating loss of $-0.476326 millions

Axim Biotechnologies, Inc announced earnings per share of $-0.01 and Sales of $0 millions in the first quarter 2017, Company's decreased loss per share, versus $-0.02 eps, earned in the same quarter a year ago, although Axim Biotechnologies, Inc saw it's Sales rise in the same period.

In the previous quarter company realized Sales of $0 millions and $-0.03 per share.

In the first quarter 2017 Axim Biotechnologies, Inc reported net loss of $-1 million, instead of deficit of $-1 millions in the same quarter a year ago.
Other AXIM's Earnings Reports

Axim Biotechnologies reported forth quarter 2016 earnings

Axim Biotechnologies reported third quarter 2016 earnings

Axim Biotechnologies reported second quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com